Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management

Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a neglected tropical disease frequently leading to permanent disabilities. The ulcers are treated with rifampicin and streptomycin, wound care and, if necessary surgical intervention. Professionals have exclusively shaped the research agenda co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS neglected tropical diseases 2016-12, Vol.10 (12), p.e0005261
Hauptverfasser: Velink, Anita, Woolley, Rebecca J, Phillips, Richard O, Abass, Kabiru M, van der Werf, Tjip S, Agumah, Emmanuel, de Zeeuw, Janine, Klis, Sandor, Stienstra, Ymkje
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 12
container_start_page e0005261
container_title PLoS neglected tropical diseases
container_volume 10
creator Velink, Anita
Woolley, Rebecca J
Phillips, Richard O
Abass, Kabiru M
van der Werf, Tjip S
Agumah, Emmanuel
de Zeeuw, Janine
Klis, Sandor
Stienstra, Ymkje
description Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a neglected tropical disease frequently leading to permanent disabilities. The ulcers are treated with rifampicin and streptomycin, wound care and, if necessary surgical intervention. Professionals have exclusively shaped the research agenda concerning management and control, while patients' perspective on priorities and preferences have not explicitly been explored or addressed. To get insight into patient perception of the management and control of Buruli ulcer a mixed methods research design was applied with a questionnaire and focus group discussions among former BU patients. Data collection was obtained in collaboration with a local team of native speakers in Ghana. A questionnaire was completed by 60 former patients and four focus group discussions were conducted with eight participants per group. Former patients positively evaluated both the effectiveness of the treatment and the financial contribution received for the travel costs to the hospitals. Pain experienced during treatment procedures, in particular wound care and the streptomycin injections, and the side-effects of the treatment were negatively evaluated. Former patients considered the development of preventive measures and knowledge on the transmission as priorities. Additionally, former patients asked for improved accessibility of health services, counselling and economic support. These findings can be used to improve clinical management and to guide the international research agenda.
doi_str_mv 10.1371/journal.pntd.0005261
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1858865048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478614775</galeid><doaj_id>oai_doaj_org_article_5adc87d99d964cdeaac1e05c75b7ef3f</doaj_id><sourcerecordid>A478614775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c624t-61d39ad0d78a7cda06a4790b98c991a25853f2058b9f03203ce35e14046be5663</originalsourceid><addsrcrecordid>eNp1Ul1rFDEUHUSxtfoPRAcEfdo1mUy-XoRaunWhRUGLj-FuktnJMjNZk0yx_96sOy27oOQhN_eec3Lv5RTFa4zmmHD8cePHMEA33w7JzBFCtGL4SXGKJaGzihP69CA-KV7EuMkYSQV-XpxUAhFCanJapIUPvQ3l5zGMnStvO50f3yA5O6T4obz8vbUhx9rGEgZT_nSxzeEN3JffbbizJeR8eTU6Y8vky8UYUpsFlv02-Fw9Ur2BAda2z8Ivi2cNdNG-mu6z4nZx-ePiy-z669Xy4vx6pllVpxnDhkgwyHABXBtADGou0UoKLSWGigpKmgpRsZINIhUi2hJqcY1qtrKUMXJWvN3rbjsf1bSwqLCgQjCKapERyz3CeNiobXA9hHvlwam_CR_WCkJyurOKgtGCGymNZLU2FkBji6jmdMVtQ5qs9Wn6bVz11ug8aIDuSPS4MrhWrf2dolXFRLVr5t0kEPyv0cb0n5Yn1BpyV25ofBbTvYtanddcMFxzTjNq_g9UPsb2TvvBNi7njwjvDwithS610Xdjcn6Ix8B6D9TBxxhs8zghRmrnzIeu1c6ZanJmpr053M4j6cGK5A-e7OAz</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1858865048</pqid></control><display><type>article</type><title>Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><creator>Velink, Anita ; Woolley, Rebecca J ; Phillips, Richard O ; Abass, Kabiru M ; van der Werf, Tjip S ; Agumah, Emmanuel ; de Zeeuw, Janine ; Klis, Sandor ; Stienstra, Ymkje</creator><contributor>Vinetz, Joseph M.</contributor><creatorcontrib>Velink, Anita ; Woolley, Rebecca J ; Phillips, Richard O ; Abass, Kabiru M ; van der Werf, Tjip S ; Agumah, Emmanuel ; de Zeeuw, Janine ; Klis, Sandor ; Stienstra, Ymkje ; Vinetz, Joseph M.</creatorcontrib><description>Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a neglected tropical disease frequently leading to permanent disabilities. The ulcers are treated with rifampicin and streptomycin, wound care and, if necessary surgical intervention. Professionals have exclusively shaped the research agenda concerning management and control, while patients' perspective on priorities and preferences have not explicitly been explored or addressed. To get insight into patient perception of the management and control of Buruli ulcer a mixed methods research design was applied with a questionnaire and focus group discussions among former BU patients. Data collection was obtained in collaboration with a local team of native speakers in Ghana. A questionnaire was completed by 60 former patients and four focus group discussions were conducted with eight participants per group. Former patients positively evaluated both the effectiveness of the treatment and the financial contribution received for the travel costs to the hospitals. Pain experienced during treatment procedures, in particular wound care and the streptomycin injections, and the side-effects of the treatment were negatively evaluated. Former patients considered the development of preventive measures and knowledge on the transmission as priorities. Additionally, former patients asked for improved accessibility of health services, counselling and economic support. These findings can be used to improve clinical management and to guide the international research agenda.</description><identifier>ISSN: 1935-2735</identifier><identifier>ISSN: 1935-2727</identifier><identifier>EISSN: 1935-2735</identifier><identifier>DOI: 10.1371/journal.pntd.0005261</identifier><identifier>PMID: 28033343</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adult ; Aged ; Agreements ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Biology and Life Sciences ; Buruli ulcer ; Buruli Ulcer - drug therapy ; Care and treatment ; Colleges &amp; universities ; Counseling ; Data collection ; Disease prevention ; Dosage and administration ; Female ; Focus Groups ; Funding ; Ghana ; Group dynamics ; Handicapped accessibility ; Humans ; Infections ; Infectious diseases ; Internal medicine ; Interviews as Topic ; Male ; Medicine ; Medicine and Health Sciences ; Middle Aged ; Mycobacterium ulcerans ; Pain ; Patient Preference ; Patients ; Qualitative research ; Research and Analysis Methods ; Rifampin ; Rifampin - adverse effects ; Rifampin - therapeutic use ; Risk factors ; Streptomycin ; Streptomycin - adverse effects ; Streptomycin - therapeutic use ; Surveys and Questionnaires ; Treatment Outcome ; Tropical diseases ; Ulcers ; Wound healing ; Young Adult</subject><ispartof>PLoS neglected tropical diseases, 2016-12, Vol.10 (12), p.e0005261</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Velink A, Woolley RJ, Phillips RO, Abass KM, van der Werf TS, Agumah E, et al. (2016) Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management. PLoS Negl Trop Dis 10(12): e0005261. doi:10.1371/journal.pntd.0005261</rights><rights>2016 Velink et al 2016 Velink et al</rights><rights>2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Velink A, Woolley RJ, Phillips RO, Abass KM, van der Werf TS, Agumah E, et al. (2016) Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management. PLoS Negl Trop Dis 10(12): e0005261. doi:10.1371/journal.pntd.0005261</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c624t-61d39ad0d78a7cda06a4790b98c991a25853f2058b9f03203ce35e14046be5663</citedby><cites>FETCH-LOGICAL-c624t-61d39ad0d78a7cda06a4790b98c991a25853f2058b9f03203ce35e14046be5663</cites><orcidid>0000-0002-8844-8859</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226828/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226828/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28033343$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Vinetz, Joseph M.</contributor><creatorcontrib>Velink, Anita</creatorcontrib><creatorcontrib>Woolley, Rebecca J</creatorcontrib><creatorcontrib>Phillips, Richard O</creatorcontrib><creatorcontrib>Abass, Kabiru M</creatorcontrib><creatorcontrib>van der Werf, Tjip S</creatorcontrib><creatorcontrib>Agumah, Emmanuel</creatorcontrib><creatorcontrib>de Zeeuw, Janine</creatorcontrib><creatorcontrib>Klis, Sandor</creatorcontrib><creatorcontrib>Stienstra, Ymkje</creatorcontrib><title>Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management</title><title>PLoS neglected tropical diseases</title><addtitle>PLoS Negl Trop Dis</addtitle><description>Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a neglected tropical disease frequently leading to permanent disabilities. The ulcers are treated with rifampicin and streptomycin, wound care and, if necessary surgical intervention. Professionals have exclusively shaped the research agenda concerning management and control, while patients' perspective on priorities and preferences have not explicitly been explored or addressed. To get insight into patient perception of the management and control of Buruli ulcer a mixed methods research design was applied with a questionnaire and focus group discussions among former BU patients. Data collection was obtained in collaboration with a local team of native speakers in Ghana. A questionnaire was completed by 60 former patients and four focus group discussions were conducted with eight participants per group. Former patients positively evaluated both the effectiveness of the treatment and the financial contribution received for the travel costs to the hospitals. Pain experienced during treatment procedures, in particular wound care and the streptomycin injections, and the side-effects of the treatment were negatively evaluated. Former patients considered the development of preventive measures and knowledge on the transmission as priorities. Additionally, former patients asked for improved accessibility of health services, counselling and economic support. These findings can be used to improve clinical management and to guide the international research agenda.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Agreements</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Biology and Life Sciences</subject><subject>Buruli ulcer</subject><subject>Buruli Ulcer - drug therapy</subject><subject>Care and treatment</subject><subject>Colleges &amp; universities</subject><subject>Counseling</subject><subject>Data collection</subject><subject>Disease prevention</subject><subject>Dosage and administration</subject><subject>Female</subject><subject>Focus Groups</subject><subject>Funding</subject><subject>Ghana</subject><subject>Group dynamics</subject><subject>Handicapped accessibility</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Internal medicine</subject><subject>Interviews as Topic</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Middle Aged</subject><subject>Mycobacterium ulcerans</subject><subject>Pain</subject><subject>Patient Preference</subject><subject>Patients</subject><subject>Qualitative research</subject><subject>Research and Analysis Methods</subject><subject>Rifampin</subject><subject>Rifampin - adverse effects</subject><subject>Rifampin - therapeutic use</subject><subject>Risk factors</subject><subject>Streptomycin</subject><subject>Streptomycin - adverse effects</subject><subject>Streptomycin - therapeutic use</subject><subject>Surveys and Questionnaires</subject><subject>Treatment Outcome</subject><subject>Tropical diseases</subject><subject>Ulcers</subject><subject>Wound healing</subject><subject>Young Adult</subject><issn>1935-2735</issn><issn>1935-2727</issn><issn>1935-2735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNp1Ul1rFDEUHUSxtfoPRAcEfdo1mUy-XoRaunWhRUGLj-FuktnJMjNZk0yx_96sOy27oOQhN_eec3Lv5RTFa4zmmHD8cePHMEA33w7JzBFCtGL4SXGKJaGzihP69CA-KV7EuMkYSQV-XpxUAhFCanJapIUPvQ3l5zGMnStvO50f3yA5O6T4obz8vbUhx9rGEgZT_nSxzeEN3JffbbizJeR8eTU6Y8vky8UYUpsFlv02-Fw9Ur2BAda2z8Ivi2cNdNG-mu6z4nZx-ePiy-z669Xy4vx6pllVpxnDhkgwyHABXBtADGou0UoKLSWGigpKmgpRsZINIhUi2hJqcY1qtrKUMXJWvN3rbjsf1bSwqLCgQjCKapERyz3CeNiobXA9hHvlwam_CR_WCkJyurOKgtGCGymNZLU2FkBji6jmdMVtQ5qs9Wn6bVz11ug8aIDuSPS4MrhWrf2dolXFRLVr5t0kEPyv0cb0n5Yn1BpyV25ofBbTvYtanddcMFxzTjNq_g9UPsb2TvvBNi7njwjvDwithS610Xdjcn6Ix8B6D9TBxxhs8zghRmrnzIeu1c6ZanJmpr053M4j6cGK5A-e7OAz</recordid><startdate>20161229</startdate><enddate>20161229</enddate><creator>Velink, Anita</creator><creator>Woolley, Rebecca J</creator><creator>Phillips, Richard O</creator><creator>Abass, Kabiru M</creator><creator>van der Werf, Tjip S</creator><creator>Agumah, Emmanuel</creator><creator>de Zeeuw, Janine</creator><creator>Klis, Sandor</creator><creator>Stienstra, Ymkje</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7SS</scope><scope>7T2</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>H95</scope><scope>H97</scope><scope>K9.</scope><scope>L.G</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8844-8859</orcidid></search><sort><creationdate>20161229</creationdate><title>Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management</title><author>Velink, Anita ; Woolley, Rebecca J ; Phillips, Richard O ; Abass, Kabiru M ; van der Werf, Tjip S ; Agumah, Emmanuel ; de Zeeuw, Janine ; Klis, Sandor ; Stienstra, Ymkje</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c624t-61d39ad0d78a7cda06a4790b98c991a25853f2058b9f03203ce35e14046be5663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Agreements</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Biology and Life Sciences</topic><topic>Buruli ulcer</topic><topic>Buruli Ulcer - drug therapy</topic><topic>Care and treatment</topic><topic>Colleges &amp; universities</topic><topic>Counseling</topic><topic>Data collection</topic><topic>Disease prevention</topic><topic>Dosage and administration</topic><topic>Female</topic><topic>Focus Groups</topic><topic>Funding</topic><topic>Ghana</topic><topic>Group dynamics</topic><topic>Handicapped accessibility</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Internal medicine</topic><topic>Interviews as Topic</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Middle Aged</topic><topic>Mycobacterium ulcerans</topic><topic>Pain</topic><topic>Patient Preference</topic><topic>Patients</topic><topic>Qualitative research</topic><topic>Research and Analysis Methods</topic><topic>Rifampin</topic><topic>Rifampin - adverse effects</topic><topic>Rifampin - therapeutic use</topic><topic>Risk factors</topic><topic>Streptomycin</topic><topic>Streptomycin - adverse effects</topic><topic>Streptomycin - therapeutic use</topic><topic>Surveys and Questionnaires</topic><topic>Treatment Outcome</topic><topic>Tropical diseases</topic><topic>Ulcers</topic><topic>Wound healing</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Velink, Anita</creatorcontrib><creatorcontrib>Woolley, Rebecca J</creatorcontrib><creatorcontrib>Phillips, Richard O</creatorcontrib><creatorcontrib>Abass, Kabiru M</creatorcontrib><creatorcontrib>van der Werf, Tjip S</creatorcontrib><creatorcontrib>Agumah, Emmanuel</creatorcontrib><creatorcontrib>de Zeeuw, Janine</creatorcontrib><creatorcontrib>Klis, Sandor</creatorcontrib><creatorcontrib>Stienstra, Ymkje</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS neglected tropical diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Velink, Anita</au><au>Woolley, Rebecca J</au><au>Phillips, Richard O</au><au>Abass, Kabiru M</au><au>van der Werf, Tjip S</au><au>Agumah, Emmanuel</au><au>de Zeeuw, Janine</au><au>Klis, Sandor</au><au>Stienstra, Ymkje</au><au>Vinetz, Joseph M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management</atitle><jtitle>PLoS neglected tropical diseases</jtitle><addtitle>PLoS Negl Trop Dis</addtitle><date>2016-12-29</date><risdate>2016</risdate><volume>10</volume><issue>12</issue><spage>e0005261</spage><pages>e0005261-</pages><issn>1935-2735</issn><issn>1935-2727</issn><eissn>1935-2735</eissn><abstract>Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a neglected tropical disease frequently leading to permanent disabilities. The ulcers are treated with rifampicin and streptomycin, wound care and, if necessary surgical intervention. Professionals have exclusively shaped the research agenda concerning management and control, while patients' perspective on priorities and preferences have not explicitly been explored or addressed. To get insight into patient perception of the management and control of Buruli ulcer a mixed methods research design was applied with a questionnaire and focus group discussions among former BU patients. Data collection was obtained in collaboration with a local team of native speakers in Ghana. A questionnaire was completed by 60 former patients and four focus group discussions were conducted with eight participants per group. Former patients positively evaluated both the effectiveness of the treatment and the financial contribution received for the travel costs to the hospitals. Pain experienced during treatment procedures, in particular wound care and the streptomycin injections, and the side-effects of the treatment were negatively evaluated. Former patients considered the development of preventive measures and knowledge on the transmission as priorities. Additionally, former patients asked for improved accessibility of health services, counselling and economic support. These findings can be used to improve clinical management and to guide the international research agenda.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>28033343</pmid><doi>10.1371/journal.pntd.0005261</doi><orcidid>https://orcid.org/0000-0002-8844-8859</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1935-2735
ispartof PLoS neglected tropical diseases, 2016-12, Vol.10 (12), p.e0005261
issn 1935-2735
1935-2727
1935-2735
language eng
recordid cdi_plos_journals_1858865048
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Public Library of Science (PLoS); PubMed Central
subjects Adolescent
Adult
Aged
Agreements
Anti-Bacterial Agents - adverse effects
Anti-Bacterial Agents - therapeutic use
Antibiotics
Biology and Life Sciences
Buruli ulcer
Buruli Ulcer - drug therapy
Care and treatment
Colleges & universities
Counseling
Data collection
Disease prevention
Dosage and administration
Female
Focus Groups
Funding
Ghana
Group dynamics
Handicapped accessibility
Humans
Infections
Infectious diseases
Internal medicine
Interviews as Topic
Male
Medicine
Medicine and Health Sciences
Middle Aged
Mycobacterium ulcerans
Pain
Patient Preference
Patients
Qualitative research
Research and Analysis Methods
Rifampin
Rifampin - adverse effects
Rifampin - therapeutic use
Risk factors
Streptomycin
Streptomycin - adverse effects
Streptomycin - therapeutic use
Surveys and Questionnaires
Treatment Outcome
Tropical diseases
Ulcers
Wound healing
Young Adult
title Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T12%3A15%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Former%20Buruli%20Ulcer%20Patients'%20Experiences%20and%20Wishes%20May%20Serve%20as%20a%20Guide%20to%20Further%20Improve%20Buruli%20Ulcer%20Management&rft.jtitle=PLoS%20neglected%20tropical%20diseases&rft.au=Velink,%20Anita&rft.date=2016-12-29&rft.volume=10&rft.issue=12&rft.spage=e0005261&rft.pages=e0005261-&rft.issn=1935-2735&rft.eissn=1935-2735&rft_id=info:doi/10.1371/journal.pntd.0005261&rft_dat=%3Cgale_plos_%3EA478614775%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1858865048&rft_id=info:pmid/28033343&rft_galeid=A478614775&rft_doaj_id=oai_doaj_org_article_5adc87d99d964cdeaac1e05c75b7ef3f&rfr_iscdi=true